JGO strives to report the most recent advances in translational and clinical research in the field of gastrointestinal oncology. JGO will feature: (1) Original Articles: Reporting on novel and original findings, and clinical observations accompanied by analysis and discussion; (2) Clinical Trial Notes: Reports that include concise descriptions of trial backgrounds/rationale, endpoints, eligibility criteria, treatment methods, scheduled analyses, and statistical considerations; (3) Case Reports: Articles with new findings that may alter the disease concept of gastrointestinal oncology; (4) Genetics Reports: Previously undescribed pathogenic germline mutations in hereditary cancer syndromes or related diseases as pedigree case reports; (5) Epidemiology Reports: New data in gastrointestinal oncology epidemiology derived from periodic or ad hoc surveillance; (6) Technical Reports: Originally devised techniques for gastrointestinal oncology diagnosis or treatment; (7) Short Communications: Small scale studies that include important new information; (8) Letters to the Editor: Letters commenting on articles published previously in the Journal or expressing views on topics relevant to GI oncology.

JGO will be published quarterly by Pioneer Bioscience Publishing Company; all articles will be submitted electronically. The entire submission and review process will be managed through Editorial Manager, an electronic system utilized to manage over 100 various journals. We are confident that authors and reviewers using this system of manuscript submission and review will find it user-friendly and straightforward.